Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST): Nilotinib PK
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
In patients who are receiving nilotinib, nilotinib plasma levels will be measured after 1
month of nilotinib treatment. The relationship between surgery type and nilotinib
pharmakokinetic properties will be investigated in this study.